pyrazolanthrone has been researched along with s 1033 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A | 1 |
Chang, SP; Chen, YC; Huang, HM; Lee, WR; Shen, SC | 1 |
Dong, Q; Ge, J; Huang, Q; Tian, S; Zhao, L; Zhu, H | 1 |
1 review(s) available for pyrazolanthrone and s 1033
Article | Year |
---|---|
Kinase Inhibitors as Underexplored Antiviral Agents.
Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses | 2022 |
2 other study(ies) available for pyrazolanthrone and s 1033
Article | Year |
---|---|
Nilotinib induction of melanogenesis via reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells.
Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Enzyme Activation; Imatinib Mesylate; MAP Kinase Kinase 4; Melanins; Melanocytes; Melanoma, Experimental; Mice; Mitochondria; Protein-Tyrosine Kinases; Pyrimidines; Reactive Oxygen Species | 2018 |
Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and differentiation of Mc3T3-E1 osteoblasts.
Topics: Aniline Compounds; Animals; Anthracenes; Cell Differentiation; Cell Line; Cell Proliferation; Dasatinib; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Nitriles; Osteoblasts; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines | 2019 |